title: Pharmacogenetics: ethical problems and solutions.
abstract: Regulators, drug companies, academic scientists, bioethicists, clinicians and, increasingly, the general public are starting to realize that pharmacogenetics (PGx) will probably have a huge impact on the way in which we treat both common and rare diseases. But how much thought has gone into the ethical issues that the incorportation of phamacogenetic testing into drug discovery, prescription and use will entail? It seems that "quite a bit" is the answer, as the diverse viewpoints of representatives of all of these groups presented here illustrate. However, these views also highlight that now is the time to start formulating and implementing solutions to these potential problems.
authors.affiliation: UK Medicines and Healthcare products Regulatory Agency.
authors.forename: Alasdair
authors.initials: A
authors.lastname: Breckenridge
authors.forename: Klaus
authors.initials: K
authors.lastname: Lindpaintner
authors.forename: Peter
authors.initials: P
authors.lastname: Lipton
authors.forename: Howard
authors.initials: H
authors.lastname: McLeod
authors.forename: Mark
authors.initials: M
authors.lastname: Rothstein
authors.forename: Helen
authors.initials: H
authors.lastname: Wallace
mesh_terms: D004992:Ethics, Medical; D006801:Humans; D010597:Pharmacogenetics / Q000941:ethics*